Janus Henderson Group’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-19,553
Closed -$113K 2576
2024
Q3
$113K Hold
19,553
﹤0.01% 2504
2024
Q2
$130K Sell
19,553
-226
-1% -$1.83K ﹤0.01% 2478
2024
Q1
$258K Buy
19,779
+3
+0% +$40 ﹤0.01% 2294
2023
Q4
$252K Sell
19,776
-33
-0.2% -$333 ﹤0.01% 2326
2023
Q3
$260K Buy
19,809
+13
+0.1% +$238 ﹤0.01% 2260
2023
Q2
$506K Buy
19,796
+11,307
+133% +$292K ﹤0.01% 1969
2023
Q1
$214K Sell
8,489
-534,791
-98% -$12.6M ﹤0.01% 2460
2022
Q4
$12.5M Sell
543,280
-785,812
-59% -$18.1M 0.01% 671
2022
Q3
$29.3M Buy
1,329,092
+664,441
+100% +$12.9M 0.01% 607
2022
Q2
$9.53M Sell
664,651
-1,761
-0.3% -$29.7K 0.01% 702
2022
Q1
$12.6M Buy
666,412
+63
+0% +$1.23K 0.01% 848
2021
Q4
$12.4M Buy
666,349
+10,423
+2% +$215K 0.01% 881
2021
Q3
$17.6M Sell
655,926
-16,633
-2% -$458K 0.01% 821
2021
Q2
$21M Buy
+672,559
New +$21.4M 0.01% 776

Other funds holding TMCI